Reward, addiction, withdrawal to nicotine

Annual Review of Neuroscience

Volumn 34, Issue , 2011, Pages 105-130

  De Biasi, Mariella ^a   Dani, John A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine; Habenula; Interpeduncular nucleus; Nucleus accumbens; Synaptic plasticity; Ventral tegmental area

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2;

ADDICTION; ARTICLE; BEHAVIOR; CHRONIC DISEASE; COGNITION; DESENSITIZATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG WITHDRAWAL; ELECTROSTIMULATION; ENDOPLASMIC RETICULUM; FOREBRAIN; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; LONG TERM EXPOSURE; MESENCEPHALON; NEUROCHEMISTRY; PRIORITY JOURNAL; PROCESSING; RECEPTOR UPREGULATION; REWARD; SENSORY STIMULATION; SEROTONINERGIC SYSTEM; TEGMENTUM; TOBACCO; WITHDRAWAL SYNDROME; WORKING MEMORY;

ANIMALS; BEHAVIOR, ADDICTIVE; CEREBRAL CORTEX; DOPAMINE; HUMANS; LIMBIC SYSTEM; NEURONAL PLASTICITY; NEURONS; NICOTINE; RECEPTORS, NICOTINIC; REWARD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 79959877467     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-061010-113734     Document Type: Article

References (296)

1. Alkondon M, Pereira EF, Barbosa CT, Albuquerque EX. 1997. Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283:1396-411 (Pubitemid 28016516)
2. Am. Psychiatr. Assoc. (APA). 2000. American Psychiatric Association, Diagnostic and Statistical Manual\IVTR. Washington, DC: APA
3. Angulo JA, McEwen BS. 1994. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Brain Res. Rev. 19:1-28 (Pubitemid 24024082)
4. Ashton H, Marsh VR, Millman JE, Rawlins MD, Telford R, Thompson JW. 1980. Biphasic dose-related responses of the CNV (contingent negative variation) to I.V. nicotine in man. Br. J. Clin. Pharmacol. 10:579-89 (Pubitemid 11243330)
5. * nicotinic receptors and dopamine pathways in the control of spontaneous locomotion. Proc. Natl. Acad. Sci. USA 105:15991-96
6. Balfour DJ. 2004. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus. Nicotine Tob. Res. 6:899-912 (Pubitemid 40124750)
7. Bennett BD, Wilson CJ. 1999. Spontaneous activity ofneostriatal cholinergic interneuronsin vitro. J. Neurosci. 19:5586-96 (Pubitemid 29300221)
8. Benowitz NL. 2001. Compensatory smoking of low yield cigarettes. In Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine, ed. DR Shopland, pp. 39-64. NIH Publ. No. 02-5074. Bethesda, MD: NIH
9. Benowitz NL. 2008. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin. Pharmacol. Ther. 83:531-41 (Pubitemid 351417076)
10. Benowitz NL. 2009. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu. Rev. Pharmacol. Toxicol. 49:57-71
11. Benowitz NL, Jacob P 3rd. 1985. Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J. Pharmacol. Exp. Ther. 234:153-55 (Pubitemid 15034904)
12. Berrendero F, Mendizabal V, Robledo P, Galeote L, Bilkei-Gorzo A, et al. 2005. Nicotine-induced antinoci-ception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 25:1103-12 (Pubitemid 40268951)
13. Berrendero F, Robledo P, Trigo JM, Martin-Garcia E, Maldonado R. 2010. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci. Biobehav. Rev. 35:220-31
14. Berrettini W, Yuan X, Tozzi F, Song K, Francks C, et al. 2008. Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol. Psychiatry 13:368-73 (Pubitemid 351399826)
15. Besson M, David V, Suarez S, Cormier A, Cazala P, et al. 2006. Genetic dissociationoftwo behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. Psychopharmacology 187:189-99 (Pubitemid 44015613)
16. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, et al. 2008. Variants in nicotinic receptors and risk for nicotine dependence. Am. J. Psychiatry 165:1163-71
17. Boulter J, O'Shea-Greenfield A, Duvoisin RM, Connolly JG, Wada E, et al. 1990. Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J. Biol. Chem. 265:4472-82
18. Bradberry CW, Lory JD, Roth RH. 1991. The anxiogenic beta-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J. Neurochem. 56:748-52 (Pubitemid 21922681)
19. Briand LA, Flagel SB, Seeman P, Robinson TE. 2008. Cocaine self-administration produces a persistent increase in dopamine D2 High receptors. Eur. Neuropsychopharmacol. 18:551-56
20. Brischoux F, Chakraborty S, Brierley DI, Ungless MA. 2009. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl. Acad. Sci. USA 106:4894-99
21. Broersen LM, Abbate F, Feenstra MG, de Bruin JP, Heinsbroek RP, Olivier B. 2000. Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat. Psychopharmacology 149:366-76 (Pubitemid 30331427)
22. Bromberg-Martin ES, Matsumoto M, Hikosaka O. 2010. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68:815-34
23. Bruijnzeel AW, Bishnoi M, van Tuijl IA, Keijzers KF, Yavarovich KR, et al. 2010. Effectsofprazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats. Psychopharmacology 212:485-99
24. Bruijnzeel AW, Gold MS. 2005. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Res. Brain Res. Rev. 49:505-28 (Pubitemid 41546656)
25. Bruijnzeel AW, Prado M, Isaac S. 2009. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol. Psychiatry 66:110-17
26. Buchhalter AR, Fant RV, Henningfield JE. 2008. Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status. Drugs 68:1067-88 (Pubitemid 351693676)
27. Buisson B, Bertrand D. 2001. Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J. Neurosci. 21:1819-29 (Pubitemid 32221365)
28. Buisson B, Bertrand D. 2002. Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol. Sci. 23:130-36 (Pubitemid 34185414)
29. Butcher LL, Woolf NJ. 1984. Histochemical distribution of acetylcholinesterase in the central nervous system: clues to the localization of cholinergic neurons. In Handbook of Chemical Neuroanatomy, Vol. 3: Classical Transmitters and Transmitter Receptors in the CNS, Part II, ed. A Björklund, T Hökfelt, MJ Kuhar, pp. 1-50. Amsterdam: Elsevier Biomed.
30. Calabresi P, Lacey MG, North RA. 1989. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br. J. Pharmacol. 98:135-40 (Pubitemid 19225212)
31. Carboni E, Bortone L, Giua C, Di Chiara G. 2000. Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend. 58:93-102
32. Carr DB, Sesack SR. 2000. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20:3864-73 (Pubitemid 30266247)
33. Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, et al. 2003. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci. 23:7820-29 (Pubitemid 37055453)
34. Changeux JP, Devillers-Thiery A, Chemouilli P. 1984. Acetylcholine receptor: an allosteric protein. Science 225:1335-45 (Pubitemid 14026339)
35. Changeux JP, Edelstein SJ. 2005. Nicotinic Acetylcholine Receptors: From Molecular Biology to Cognition. New York: Odile Jacob
36. Chergui K, Suaud-Chagny MF, Gonon F. 1994. Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience 62:641-45
37. Christoph GR, Leonzio RJ, Wilcox KS. 1986. Stimulationofthe lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat. J. Neurosci. 6:613-19 (Pubitemid 16134900)
38. Conover KL, Woodside B, Shizgal P. 1994. Effects of sodium depletion on competition and summation between rewarding effects of salt and lateral hypothalamic stimulation in the rat. Behav. Neurosci. 108:549-58 (Pubitemid 24200063)
39. Corbett D, Wise RA. 1979. Intracranial self-stimulation in relation to the ascending noradrenergic fiber systems of the pontine tegmentum and caudal midbrain: a moveable electrode mapping study. Brain Res. 177:423-36 (Pubitemid 10241278)
40. Corrigall WA. 1999. Nicotine self-administration in animals as a dependence model. Nicotine Tob. Res. 1:11-20
41. Corringer PJ, Sallette J, Changeux JP. 2006. Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural plasticity? J. Physiol. 99:162-71
42. Cragg SJ. 2003. Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J. Neurosci. 23:4378-85 (Pubitemid 36958459)
43. Cragg SJ, Hille CJ, Greenfield SA. 2002. Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine. J. Neurosci. 22:5705-12 (Pubitemid 35386492)
44. Cryan JF, Bruijnzeel AW, Skjei KL, Markou A. 2003. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology 168:347-58 (Pubitemid 36920920)
45. Dalley JW, Everitt BJ. 2009. Dopamine receptors in the learning, memory and drug reward circuitry. Semin. Cell Dev. Biol. 20:403-10
46. Damaj MI, Kao W, Martin BR. 2003. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J. Pharmacol. Exp. Ther. 307:526-34 (Pubitemid 37310665)
47. Dani JA, Bertrand D. 2007. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47:699-729
48. Dani JA, Harris RA. 2005. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat. Neurosci. 8:1465-70 (Pubitemid 41573657)
49. Dani JA, Heinemann S. 1996. Molecular and cellular aspects of nicotine abuse. Neuron 16:905-8 (Pubitemid 26171196)
50. Dani JA, Ji D, Zhou FM. 2001. Synaptic plasticity and nicotine addiction. Neuron 31:349-52 (Pubitemid 32778555)
51. Dani JA, Kosten TR, Benowitz NL. 2009. The pharmacology of nicotine and tobacco. In Principles of Addiction Medicine, ed. RK Ries, DA Fiellin, SC Miller, R Saitz, pp. 179-91. Philadelphia, PA: Wolters Kluwer/Lippincott, Williams & Wilkins
52. Dani JA, Montague PR. 2007. Disrupting addiction through the loss of drug-associated internal states. Nat. Neurosci. 10:403-4 (Pubitemid 46494578)
53. Dani JA, Radcliffe KA, Pidoplichko VI. 2000. Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur. J. Pharmacol. 393:31-38 (Pubitemid 30193398)
54. Darsow T, Booker TK, Pina-Crespo JC, Heinemann SF. 2005. Exocytic trafficking is required for nicotine-induced up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors. J. Biol. Chem. 280:18311-20 (Pubitemid 41389077)
55. Davis JA, James JR, Siegel SJ, Gould TJ. 2005. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J. Neurosci. 25:8708-13 (Pubitemid 41362049)
56. De Biasi M, Salas R. 2008. Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal. Exp. Biol. Med. 233:917-29
57. de Rover M, Lodder JC, Kits KS, Schoffelmeer AN, Brussaard AB. 2002. Cholinergic modulation of nucleus accumbens medium spiny neurons. Eur. J. Neurosci. 16:2279-90 (Pubitemid 36056952)
58. Devine DP, Leone P, Pocock D, Wise RA. 1993. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266:1236-46 (Pubitemid 24175764)
59. Di Chiara G. 1999. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375:13-30 (Pubitemid 29317589)
60. Di Chiara G. 2000. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393:295-314 (Pubitemid 30193428)
61. Di Chiara G, Imperato A. 1988. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1067-80 (Pubitemid 18090131)
62. * nicotinic acetylcholine receptors. J. Neurosci. 30:9877-89
63. Duchemin AM, Zhang H, Neff NH, Hadjiconstantinou M. 2009. Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal. Neurosci. Lett. 467:182-86
64. Ellison G. 2002. Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry. Eur. Neuropsychopharmacol. 12:287-97 (Pubitemid 34753099)
65. Ellison G, Irwin S, Keys A, Noguchi K, Sulur G. 1996. The neurotoxic effects of continuous cocaine and amphetamine in Habenula: implications for the substrates of psychosis. NIDA Res. Monogr. 163:117-45
66. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. 1998. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76-79 (Pubitemid 28240257)
67. Erhardt S, Schwieler L, Engberg G. 2002. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine. Synapse 43:227-37 (Pubitemid 34118259)
68. Exley R, Cragg SJ. 2008. Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br. J. Pharmacol. 153(Suppl. 1):S283-97 (Pubitemid 351340986)
69. Fattore L, Cossu G, Martellotta MC, Fratta W. 2002. Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol. 37:495-98
70. Fenster CP, Whitworth TL, Sheffield EB, Quick MW, Lester RA. 1999. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J. Neurosci. 19:4804-14 (Pubitemid 29270117)
71. Fibiger HC. 1978. Drugs and reinforcement mechanisms: a critical review of the catecholamine theory. Annu. Rev. Pharmacol. Toxicol. 18:37-56
72. Fletcher PJ, Le AD, Higgins GA. 2008. Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog. Brain Res. 172:361-83
73. Flores CM, Davila-Garcia MI, Ulrich YM, Kellar KJ. 1997. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J. Neurochem. 69:2216-19 (Pubitemid 27452771)
74. Floresco SB, West AR, Ash B, Moore H, Grace AA. 2003. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat. Neurosci. 6:968-73 (Pubitemid 37064759)
75. Fouriezos G, Wise RA. 1976. Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits. Brain Res. 103:377-80
76. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. 2011. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature. In Press
77. Gaddnas H, Piepponen TP, Ahtee L. 2002. Mecamylamine decreases accumbal dopamine output in mice treated chronically with nicotine. Neurosci. Lett. 330:219-22 (Pubitemid 35254039)
78. Gaimarri A, Moretti M, Riganti L, Zanardi A, Clementi F, Gotti C. 2007. Regulation of neuronal nicotinic receptor traffic and expression. Brain Res. Rev. 55:134-43 (Pubitemid 47353824)
79. Gangitano D, Salas R, Teng Y, Perez E, De Biasi M. 2009. Progesterone modulation of alpha5 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes Brain Behav. 8:398-406
80. Gao M, Jin Y, Yang K, Zhang D, Lukas RJ, Wu J. 2010. Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticityondopamine neuronsinthe ventral tegmental area.J. Neurosci.30:13814-25
81. Garris PA, Kilpatrick M, Bunin MA, Michael D, Walker QD, Wightman RM. 1999. Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398:67-69
82. Geisler S, Marinelli M, Degarmo B, Becker ML, Freiman AJ, et al. 2008. Prominent activation of brainstem and pallidal afferents of the ventral tegmental area by cocaine. Neuropsychopharmacology 33:2688-700
83. George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, et al. 2007. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc. Natl. Acad. Sci. USA 104:17198-203 (Pubitemid 350211014)
84. Glick SD, Maisonneuve IM, Kitchen BA, Fleck MW. 2002. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur. J. Pharmacol. 438:99-105 (Pubitemid 34242925)
85. Gonon FG. 1988. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19-28 (Pubitemid 18044238)
86. Grabus SD, Martin BR, Imad Damaj M. 2005. Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype. Eur. J. Pharmacol. 515:90-93 (Pubitemid 40779272)
87. Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24
88. Grace AA, Bunney BS. 1983. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10:301-15 (Pubitemid 13019570)
89. Grace AA, Bunney BS. 1984. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4:2866-76 (Pubitemid 15224431)
90. Grace AA, Floresco SB, Goto Y, Lodge DJ. 2007. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 30:220-27 (Pubitemid 46654234)
91. Grady SR, Grun EU, Marks MJ, Collins AC. 1997. Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. J. Pharmacol. Exp. Ther. 282:32-43 (Pubitemid 27425524)
92. Grady SR, Marks MJ, Collins AC. 1994. Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes. J. Neurochem. 62:1390-98
93. * subtypes mediate acetylcholine release. J. Neurosci. 29:2272-82
94. *-nicotinic acetylcholine receptors. J. Mol. Neurosci. 40:91-95
95. Gratton A, Hoffer BJ, Gerhardt GA. 1988. Effects of electrical stimulation of brain reward sites on release of dopamine in rat: an in vivo electrochemical study. Brain Res. Bull. 21:319-24 (Pubitemid 19268479)
96. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. 1996. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 83:713-16 (Pubitemid 26360646)
97. Greatrex RM, Phillipson OT. 1982. Demonstration of synaptic input from prefrontal cortex to the habenula in the rat. Brain Res. 238:192-97 (Pubitemid 12158448)
98. Grenhoff J, Aston-Jones G, Svensson TH. 1986. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol. Scand. 128:351-58 (Pubitemid 17182735)
99. Grigoriadis D, Seeman P. 1986. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain. Naunyn-Schmiedebergs Arch. Pharmakol. 332:21-25 (Pubitemid 16149707)
100. Groenewegen HJ, Ahlenius S, Haber SN, Kowall NW, Nauta WJ. 1986. Cytoarchitecture, fiber connections, and some histochemical aspects of the interpeduncular nucleus in the rat. J. Comp. Neurol. 249:65-102 (Pubitemid 16096990)
101. Grottick AJ, Higgins GA. 2000. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav. Brain Res. 117:197-208
102. Haber SN, Fudge JL, McFarland NR. 2000. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 20:2369-82 (Pubitemid 30230089)
103. Hadjiconstantinou M, Neff NH. 2011. Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology. In Press
104. Harrison AA, Liem YT, Markou A. 2001. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychophar-macology 25:55-71 (Pubitemid 32493822)
105. Heimer L. 2000. Basal forebrain in the context of schizophrenia. Brain Res. Brain Res. Rev. 31:205-35 (Pubitemid 30136178)
106. Herkenham M, Nauta WJ. 1977. Afferent connections of the habenular nuclei in the rat. A horseradish peroxidase study, with a note on the fiber-of-passage problem. J. Comp. Neurol. 173:123-46
107. Herkenham M, Nauta WJ. 1979. Efferent connections of the habenular nuclei in the rat. J. Comp. Neurol. 187:19-47
108. Herskovic JE, Rose JE, Jarvik ME. 1986. Cigarette desirability and nicotine preference in smokers. Pharmacol. Biochem. Behav. 24:171-75 (Pubitemid 16185576)
109. Hikosaka O. 2010. The habenula: from stress evasion to value-based decision-making. Nat. Rev. Neurosci. 11:503-13
110. Hikosaka O, Bromberg-Martin E, Hong S, Matsumoto M. 2008. New insights on the subcortical representation of reward. Curr. Opin. Neurobiol. 18:203-8
111. Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B, Svensson TH. 1998. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res. 779:214-25 (Pubitemid 28039954)
112. Hodos W. 1961. Progressive ratio as a measure of reward strength. Science 134:943-44
113. Hogle JM, Kaye JT, Curtin JJ. 2010. Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction. Biol. Psychiatry 68:719-25
114. Hughes JR. 2007. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob. Res. 9:315-27 (Pubitemid 46404264)
115. Hutchison MA, Riley AL. 2008. Adolescent exposure to nicotine alters the aversive effects of cocaine in adult rats. Neurotoxicol. Teratol. 30:404-11
116. Hwang YY, Li MD. 2006. Proteins differentially expressed in response to nicotine in five rat brain regions: identification using a 2-DE/MS-based proteomics approach. Proteomics 6:3138-53 (Pubitemid 43806410)
117. Hyland BI, Reynolds JN, Hay J, Perk CG, Miller R. 2002. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114:475-92 (Pubitemid 35245426)
118. Ikemoto S. 2010. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci. Biobehav. Rev. 35:129-50
119. Imperato A, Mulas A, Di Chiara G. 1986. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132:337-38 (Pubitemid 17003483)
120. Inglis FM, Moghaddam B. 1999. Dopaminergic innervation of the amygdala is highly responsive to stress. J. Neurochem. 72:1088-94 (Pubitemid 29085023)
121. Irvine EE, Cheeta S, File SE. 2001. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol. Biochem. Behav. 68:319-25 (Pubitemid 32231194)
122. Ishii K, Wong JK, Sumikawa K. 2005. Comparison of alpha2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice. J. Comp. Neurol. 493:241-60 (Pubitemid 41677479)
123. Isola R, Vogelsberg V, Wemlinger TA, Neff NH, Hadjiconstantinou M. 1999. Nicotine abstinence in the mouse. Brain Res. 850:189-96
124. Isola R, Zhang H, Tejwani GA, Neff NH, Hadjiconstantinou M. 2008. Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal. Synapse 62:448-55 (Pubitemid 351614769)
125. Jackson KJ, Kota DH, Martin BR, Damaj MI. 2009. The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology 56:970-74
126. Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC. 2009a. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 61:786-800
127. Jhou TC, Geisler S, Marinelli M, Degarmo BA, Zahm DS. 2009b. The mesopontine rostromedial tegmental nucleus: a structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J. Comp. Neurol. 513:566-96
128. Ji H, Shepard PD. 2007. Lateral habenula stimulation inhibits rat midbrain dopamine neurons through a GABA(A) receptor-mediated mechanism. J. Neurosci. 27:6923-30 (Pubitemid 47015898)
129. Jones IW, Bolam JP, Wonnacott S. 2001. Presynaptic localisation of the nicotinic acetylcholine receptor beta2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones. J. Comp. Neurol. 439:235-47 (Pubitemid 32906025)
130. Kalivas PW. 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev. 18:75-113 (Pubitemid 23090012)
131. Kassel JD, Greenstein JE, Evatt DP, Wardle MC, Yates MC, et al. 2007. Smoking topography in response to denicotinized and high-yield nicotine cigarettes in adolescent smokers. J. Adolesc. Health 40:54-60 (Pubitemid 44918375)
132. Kauer JA, Malenka RC. 2007. Synaptic plasticity and addiction. Nat. Rev. Neurosci. 8:844-58 (Pubitemid 350006216)
133. Kawasaki H, Kaufman O, Damasio H, Damasio AR, Granner M, et al. 2001. Single-neuron responses to emotional visual stimuli recorded in human ventral prefrontal cortex. Nat. Neurosci. 4:15-16 (Pubitemid 32095520)
134. Kenny PJ. 2010. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol. Biochem. Behav. 97:700-7
135. Kenny PJ, Markou A. 2001. Neurobiology of the nicotine withdrawal syndrome. Pharmacol. Biochem. Behav. 70:531-49 (Pubitemid 34131647)
136. Kim U, Chang SY. 2005. Dendritic morphology, local circuitry, and intrinsic electrophysiology of neurons in the rat medial and lateral habenular nuclei of the epithalamus. J. Comp. Neurol. 483:236-50 (Pubitemid 40189800)
137. Klemm WR. 2004. Habenular and interpeduncularis nuclei: shared components in multiple-function networks. Med. Sci. Monit. 10:RA261-73 (Pubitemid 39546049)
138. Klink R, de Kerchove d'Exaerde A, Zoli M, Changeux JP. 2001. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21:1452-63 (Pubitemid 32182187)
139. Koob G, Kreek MJ. 2007. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry 164:1149-59 (Pubitemid 47292402)
140. Koob GF. 2008. A role for brain stress systems in addiction. Neuron 59:11-34 (Pubitemid 351905857)
141. Koob GF, Le Moal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129
142. Koob GF, Le Moal M. 2005. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 8:1442-44 (Pubitemid 41573653)
143. Koob GF, Volkow ND. 2009. Neurocircuitry of addiction. Neuropsychopharmacology 35:217-38
144. Koos T, Tepper JM. 2002. Dual cholinergic control of fast-spiking interneurons in the neostriatum. J. Neurosci. 22:529-35 (Pubitemid 34049092)
145. Lanca AJ, Adamson KL, Coen KM, Chow BL, Corrigall WA. 2000. The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study. Neuroscience 96:735-42 (Pubitemid 30155737)
146. Lau B, Bretaud S, Huang Y, Lin E, Guo S. 2006. Dissociation of food and opiate preference by a genetic mutation in zebrafish. Genes Brain Behav. 5:497-505 (Pubitemid 44423508)
147. Laviolette SR. 2007. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia? Schizophr. Bull. 33:971-81 (Pubitemid 47216650)
148. Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, et al. 2010. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells.Neuropsychopharmacology 36:589-602
149. Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, et al. 2009. Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J. 11:167-77
150. Lippa AS, Antelman SM, Fisher AE, Canfield DR. 1973. Neurochemical mediation of reward: a significant role for dopamine? Pharmacol. Biochem. Behav. 1:23-28
151. Lisoprawski A, Herve D, Blanc G, Glowinski J, Tassin JP. 1980. Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat. Brain Res. 183:229-34 (Pubitemid 10116798)
152. Lodge DJ, Grace AA. 2006. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc. Natl. Acad. Sci. USA 103:5167-72
153. Longoni R, Spina L, Mulas A, Carboni E, Garau L, et al. 1991. (D-Ala2)deltorphin II: D1-dependent stereo-typies and stimulation of dopamine release in the nucleus accumbens. J. Neurosci. 11:1565-76
154. Maisonneuve IM, Glick SD. 2003. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol. Biochem. Behav. 75:607-18 (Pubitemid 36936895)
155. Malin DH, Goyarzu P. 2009. Rodent models of nicotine withdrawal syndrome. Handb. Exp. Pharmacol. 2009:401-34
156. Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, et al. 1992. Rodent model of nicotine abstinence syndrome. Pharmacol. Biochem. Behav. 43:779-84
157. Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, et al. 2006. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50:911-21 (Pubitemid 43850688)
158. Mansvelder HD, Keath JR, McGehee DS. 2002. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-19 (Pubitemid 34246356)
159. Mansvelder HD, McGehee DS. 2000. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27:349-57
160. Mansvelder HD, McGehee DS. 2002. Cellular and synaptic mechanisms of nicotine addiction. J. Neurobiol. 53:606-17 (Pubitemid 35375590)
161. Marinelli M, Rudick CN, Hu XT, White FJ. 2006. Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol. Disord. Drug Targets 5:79-97 (Pubitemid 43803125)
162. Marks MJ, Burch JB, Collins AC. 1983. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226:817-25 (Pubitemid 13007732)
163. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, et al. 1992. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12:2765-84
164. Maskos U. 2008. The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology. Br. J. Pharmacol. 153(Suppl. 1):S438-45 (Pubitemid 351341023)
165. Maskos U. 2010. Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors. J. Neurochem. 114:641-6
166. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, et al. 2005. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436:103-7 (Pubitemid 40966193)
167. Mathers CD, Loncar D. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3:e442
168. Matsumoto M, Hikosaka O. 2007. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 447:1111-15 (Pubitemid 47014424)
169. Matsumoto M, Hikosaka O. 2009. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 459:837-41
170. McCallum SE, Parameswaran N, Bordia T, Fan H, McIntosh JM, Quik M. 2006. Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys. J. Pharmacol. Exp. Ther. 318:381-88 (Pubitemid 43922326)
171. McClure SM, Ericson KM, Laibson DI, Loewenstein G, Cohen JD. 2007. Time discounting for primary rewards. J. Neurosci. 27:5796-804 (Pubitemid 350021085)
172. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. 1995. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-96
173. * nAChRs by self-administered and non-contingent nicotine in C57BL/6J mice. Addict. Biol. 15:464-79
174. Mogenson GJ, Jones DL, Yim CY. 1980. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14:69-97 (Pubitemid 10053405)
175. Montague PR, King-Casas B, Cohen JD. 2006. Imaging valuation models in human choice. Annu. Rev. Neurosci. 29:417-48 (Pubitemid 44476852)
176. Montone KT, Fass B, Hamill GS. 1988. Serotonergic and nonserotonergic projections from the rat interpe-duncular nucleus to the septum, hippocampal formation and raphe: a combined immunocytochemical and fluorescent retrograde labelling study of neurons in the apical subnucleus. Brain Res. Bull. 20:233-40 (Pubitemid 19017211)
177. Nguyen HN, Rasmussen BA, Perry DC. 2004. Binding and functional activityofnicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment. J. Neurochem. 90:40-49 (Pubitemid 38879160)
178. Nishikawa T, Fage D, Scatton B. 1986. Evidence for, and nature of, the tonic inhibitory influence of habenu-lointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. Brain Res. 373:324-36 (Pubitemid 16039909)
179. Novak G, Seeman P, Le Foll B. 2010. Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity. Int. J. Neurosci. 120:691-97
180. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. 2001. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat. Neurosci. 4:95-102 (Pubitemid 32095532)
181. Olds J. 1958. Self-stimulation of the brain: its use to study local effects of hunger, sex, and drugs. Science 127:315-24
182. Olds J, Milner P. 1954. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47:419-27
183. Olds ME, Olds J. 1969. Effects of lesions in medial forebrain bundle on self-stimulation behavior. Am. J. Physiol. 217:1253-64
184. Omelchenko N, Sesack SR. 2005. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area. J. Comp. Neurol. 483:217-35 (Pubitemid 40189799)
185. Packard MG, Knowlton BJ. 2002. Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci. 25:563-93 (Pubitemid 34748029)
186. Paterson NE, Markou A. 2007. Animal models and treatments for addiction and depression co-morbidity. Neurotox. Res. 11:1-32
187. Paterson NE, Semenova S, Gasparini F, Markou A. 2003. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167:257-64 (Pubitemid 36712972)
188. Pauly JR, Marks MJ, Robinson SF, van de Kamp JL, Collins AC. 1996. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. J. Pharmacol. Exp. Ther. 278:361-69 (Pubitemid 27167115)
189. Pellow S, Chopin P, File SE, Briley M. 1985. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-67 (Pubitemid 16239568)
190. Peng X, Gerzanich V, Anand R, Wang F, Lindstrom J. 1997. Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 51:776-84 (Pubitemid 27224682)
191. Pennartz CM, Groenewegen HJ, Lopes da Silva FH. 1994. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: anintegration ofbehavioural, electrophysiological and anatomical data.Prog. Neurobiol. 42:719-61 (Pubitemid 24199524)
192. Pentney RJ, Gratton A. 1991. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience 45:95-102
193. Perrotti LI, Bolanos CA, Choi KH, Russo SJ, Edwards S, et al. 2005. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur. J. Neurosci. 21:2817-24 (Pubitemid 40835124)
194. Perry E, Walker M, Grace J, Perry R. 1999. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 22:273-80 (Pubitemid 29259995)
195. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. 1996. Mortality from smoking worldwide. Br. Med. Bull. 52:12-21 (Pubitemid 26039045)
196. Phillips AG, Blaha CD, Fibiger HC. 1989. Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci. Biobehav. Rev. 13:99-104 (Pubitemid 19241923)
197. Phillips MI, Olds J. 1969. Unit activity: motiviation-dependent responses from midbrain neurons. Science 165:1269-71
198. Picciotto MR, Addy NA, Mineur YS, Brunzell DH. 2008. It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog. Neurobiol. 84:329-42
199. Picciotto MR, Corrigall WA. 2002. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J. Neurosci. 22:3338-41 (Pubitemid 37465738)
200. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, et al. 1998. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-77 (Pubitemid 28092475)
201. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA. 1997. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390:401-4 (Pubitemid 28027320)
202. Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, et al. 2004. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn. Mem. 11:60-69 (Pubitemid 38167059)
203. Placzek AN, Zhang TA, Dani JA. 2009. Age dependent nicotinic influences over dopamine neuron synaptic plasticity. Biochem. Pharmacol. 78:686-92
204. Pomerleau OF, Pomerleau CS, Mehringer AM, Snedecor SM, Ninowski R, Sen A. 2005.Nicotinedependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine Tob. Res. 7:91-102 (Pubitemid 40613166)
205. Pons S, Fattore L, Cossu G, Tolu S, Porcu E, et al. 2008. Crucial role of alpha4 and alpha6 nicotinic acetyl-choline receptor subunits from ventral tegmental area in systemic nicotine self-administration. J. Neurosci. 28:12318-27
206. Pontieri FE, Tanda G, Orzi F, Di Chiara G. 1996. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-57 (Pubitemid 26251360)
207. Portugal GS, Kenney JW, Gould TJ. 2008. Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol. Learn. Mem. 89:106-13 (Pubitemid 350235960)
208. Qin J, Wheeler AR. 2007. Maze exploration and learning in C. elegans. Lab Chip 7:186-92 (Pubitemid 46238541)
209. Rada P, Jensen K, Hoebel BG. 2001. Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology 157:105-10 (Pubitemid 32758966)
210. Rahman S, Zhang J, Engleman EA, Corrigall WA. 2004. Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study. Neuroscience 129:415-24 (Pubitemid 39388860)
211. Rezvani AH, Slade S, Wells C, Petro A, Lumeng L, et al. 2010. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. Psychopharmacology 211:161-74
212. Rezvani K, Teng Y, De Biasi M. 2009. The ubiquitin-proteasome system regulates the stability of neuronal nicotinic acetylcholine receptors. J. Mol. Neurosci. 40:177-84
213. Rezvani K, Teng Y, Shim D, De Biasi M. 2007. Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. J. Neurosci. 27:10508-19 (Pubitemid 47501994)
214. Rice ME, Cragg SJ. 2004. Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7:583-84 (Pubitemid 38691894)
215. Robinson S, Smith DM, Mizumori SJ, Palmiter RD. 2004. Firing properties of dopamine neurons in freely moving dopamine-deficient mice: effects of dopamine receptor activation and anesthesia. Proc. Natl. Acad. Sci. USA 101:13329-34 (Pubitemid 39209665)
216. Roitman MF, Wheeler RA, Carelli RM. 2005. Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output. Neuron 45:587-97 (Pubitemid 40249870)
217. Roitman MF, Wheeler RA, Wightman RM, Carelli RM. 2008. Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat. Neurosci. 11:1376-77
218. Role LW, Berg DK. 1996. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-85 (Pubitemid 26227229)
219. Rossetti ZL, Hmaidan Y, Gessa GL. 1992. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221:227-34
220. Routtenberg A, Lindy J. 1965. Effects of the availability of rewarding septal and hypothalamic stimulation on bar pressing for food under conditions of deprivation. J. Comp. Physiol. Psychol. 60:158-61
221. Rowell PP, Wonnacott S. 1990. Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J. Neurochem. 55:2105-10 (Pubitemid 120021846)
222. Saal D, Dong Y, Bonci A, Malenka RC. 2003. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-82 (Pubitemid 36262980)
223. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, et al. 2007. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 16:36-49 (Pubitemid 46152543)
224. Salas R, Baldwin P, De Biasi M, Montague PR. 2010. BOLD responses to negative reward prediction errors in human habenula. Front. Hum. Neurosci. 4:36
225. Salas R, Cook KD, Bassetto L, De Biasi M. 2004a. The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47:401-7 (Pubitemid 38953231)
226. Salas R, Main A, Gangitano D, De Biasi M. 2007. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit. Neuropharmacology 53:863-69 (Pubitemid 350018825)
227. Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M. 2003a. The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol. Pharmacol. 63:1059-66 (Pubitemid 36529924)
228. Salas R, Pieri F, De Biasi M. 2004b. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J. Neurosci. 24:10035-39 (Pubitemid 39492026)
229. Salas R, Pieri F, Fung B, Dani JA, De Biasi M. 2003b. Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J. Neurosci. 23:6255-63 (Pubitemid 36875627)
230. Salas R, Sturm R, Boulter J, De Biasi M. 2009. Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J. Neurosci. 29:3014-18
231. Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, et al. 2005. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46:595-607
232. Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR. 2007. Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Mol. Pharmacol. 71:1563-71 (Pubitemid 47010909)
233. Scheibel AB. 1997. The thalamus and neuropsychiatric illness. J. Neuropsychiatry Clin. Neurosci. 9:342-53 (Pubitemid 27363941)
234. * nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38:375-83
235. Schilstrom B, Rawal N, Mameli-Engvall M, Nomikos GG, Svensson TH. 2003. Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes. Int. J. Neuropsychopharmacol. 6:1-11 (Pubitemid 36373095)
236. Schultz W. 2006. Behavioral theories and the neurophysiology of reward. Annu. Rev. Psychol. 57:87-115 (Pubitemid 43237228)
237. Schultz W. 2007a. Behavioral dopamine signals. Trends Neurosci. 30:203-10 (Pubitemid 46654238)
238. Schultz W. 2007b. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 30:259-88 (Pubitemid 47218758)
239. Schultz W. 2010. Dopamine signals for reward value and risk: basic and recent data. Behav. Brain Funct. 6:24
240. Schultz W, Dayan P, Montague PR. 1997. A neural substrate of prediction and reward. Science 275:1593-99 (Pubitemid 27120526)
241. Schwartz RD, Kellar KJ. 1983. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214-16 (Pubitemid 13115272)
242. Seamans JK, Yang CR. 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74:1-58
243. Semenova S, Markou A. 2010. The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. Eur. Neuropsychopharmacol. 20:731-46
244. Shepard PD, Holcomb HH, Gold JM. 2006. Schizophrenia in translation: the presence of absence: habenular regulation of dopamine neurons and the encoding of negative outcomes. Schizophr. Bull. 32:417-21 (Pubitemid 43992313)
245. Shiffman S, Gwaltney CJ, Balabanis MH, Liu KS, Paty JA, et al. 2002. Immediate antecedents of cigarette smoking: an analysis from ecological momentary assessment. J. Abnorm. Psychol. 111:531-45 (Pubitemid 35246999)
246. Simpson GR, Riley AL. 2005. Morphine preexposure facilitates morphine place preference and attenuates morphine taste aversion. Pharmacol. Biochem. Behav. 80:471-79 (Pubitemid 40299349)
247. Slotkin TA, Seidler FJ. 2007. A unique role for striatal serotonergic systems in the withdrawal from adolescent nicotine administration. Neurotoxicol. Teratol. 29:10-16 (Pubitemid 46205155)
248. Smolka MN, Bühler M, Klein S, Zimmermann U, Mann K, et al. 2005. Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology 184:1-12
249. Spanagel R, Herz A, Shippenberg TS. 1990a. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1734-40
250. Spanagel R, Herz A, Shippenberg TS. 1990b. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens.Eur. J. Pharmacol. 190:177-84 (Pubitemid 20372320)
251. Spanagel R, Herz A, Shippenberg TS. 1992. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89:2046-50
252. Spies G. 1965. Food versus intracranial self-stimulation reinforcement in food-deprived rats. J. Comp. Physiol. Psychol. 60:153-57
253. Steffensen SC, Svingos AL, Pickel VM, Henriksen SJ. 1998. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci. 18:8003-15 (Pubitemid 28441038)
254. Steiner H, Gerfen CR. 1998. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123:60-76 (Pubitemid 28495297)
255. Stellar JR, Corbett D. 1989. Regional neuroleptic microinjections indicate a role for nucleus accumbens in lateral hypothalamic self-stimulation reward. Brain Res. 477:126-43 (Pubitemid 19026946)
256. Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk L. 2004. The role of nicotinic receptor alpha 7 subunits in nicotine discrimination. Neuropharmacology 46:363-71 (Pubitemid 38223869)
257. Stolerman IP, Shoaib M. 1991. The neurobiology of tobacco addiction. Trends Pharmacol. Sci. 12:467-73
258. Sutherland RJ. 1982. The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex. Neurosci. Biobehav. Rev. 6:1-13 (Pubitemid 12108675)
259. Sutherland RJ, Nakajima S. 1981. Self-stimulation of the habenular complex in the rat. J. Comp. Physiol. Psychol. 95:781-91
260. Suzuki T, Ise Y, Tsuda M, Maeda J, Misawa M. 1996. Mecamylamine- precipitated nicotine-withdrawal aversion in rats. Eur. J. Pharmacol. 314:281-84 (Pubitemid 26382429)
261. Tang J, Dani JA. 2009. Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine. Neuron 63:673-82
262. * receptors: sufficient for reward, tolerance, and sensitization. Science 306:1029-32 (Pubitemid 39482905)
263. Thierry AM, Tassin JP, Blanc G, Glowinski J. 1976. Selective activation of mesocortical DA system by stress. Nature 263:242-44
264. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. 2008. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638-42 (Pubitemid 351483366)
265. Thorndike EL, ed. 1911. Animal Intelligence. New York: Macmillan
266. Trigo JM, Martin-Garcia E, Berrendero F, Robledo P, Maldonado R. 2009. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend. 108:183-94
267. Ullsperger M, von Cramon DY. 2003. Error monitoring using external feedback: specific roles of the habenular complex, the reward system, and the cingulate motor area revealed by functional magnetic resonance imaging. J. Neurosci. 23:4308-14 (Pubitemid 36958451)
268. Ungless MA, Magill PJ, Bolam JP. 2004. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303:2040-42 (Pubitemid 38393283)
269. Vallejo YF, Buisson B, Bertrand D, Green WN. 2005. Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J. Neurosci. 25:5563-72 (Pubitemid 40800648)
270. van Domburg PHMF, ten Donkelaar HJ. 1991. The human substantia nigra and ventral tegmental area. Adv. Anat. Embryol. Cell Biol. 121:1-132
271. Vastag B. 2005. Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'. Science 308:345-46
272. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ. 2002. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol. Learn. Mem. 78:610-24 (Pubitemid 36268682)
273. Walaas I, Fonnum F. 1980. Biochemical evidence for gamma-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat. Neuroscience 5:63-72 (Pubitemid 10203401)
274. Walters CL, Brown S, Changeux JP, Martin B, Damaj MI. 2006. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology 184:339-44 (Pubitemid 43255850)
275. Watkins SS, Stinus L, Koob GF, Markou A. 2000. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J. Pharmacol. Exp. Ther. 292:1053-64 (Pubitemid 30136601)
276. Weiss F, Markou A, Lorang MT, Koob GF. 1992. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593:314-18
277. West RJ, Hajek P, Belcher M. 1989. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol. Med. 19:981-85 (Pubitemid 20012264)
278. Whiteaker P, Davies AR, Marks MJ, Blagbrough IS, Potter BV, et al. 1999. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur. J. Neurosci. 11:2689-96 (Pubitemid 29365411)
279. Wilson CJ. 2004. Basal ganglia. In The Synaptic Organization of the Brain, ed. GM Shepherd, pp. 361-413. Oxford, UK: Oxford Univ. Press
280. Winter C, Vollmayr B, Djodari-Irani A, Klein J, Sartorius A. 2010. Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression. Behav. Brain Res. 216:463-65
281. Wise RA. 1978. Catecholamine theories of reward: a critical review. Brain Res. 152:215-47 (Pubitemid 9003327)
282. Wise RA. 2004. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5:483-94 (Pubitemid 38715515)
283. Wise RA. 2006. Role of brain dopamine in food reward and reinforcement. Philos. Trans. R. Soc. Lond. B 361:1149-58 (Pubitemid 44874226)
284. Wise RA. 2009. Roles for nigrostriatal\not just mesocorticolimbic\ dopamine in reward and addiction. Trends Neurosci. 32:517-24
285. Wise RA, Rompre PP. 1989. Brain dopamine and reward. Annu. Rev. Psychol. 40:191-225
286. Wise RA, Yokel RA, DeWit H. 1976. Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats. Science 191:1273-75
287. Wonnacott S, Kaiser S, Mogg A, Soliakov L, Jones IW. 2000. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur. J. Pharmacol. 393:51-58 (Pubitemid 30193400)
288. Wonnacott S, Sidhpura N, Balfour DJ. 2005. Nicotine: from molecular mechanisms to behaviour. Curr. Opin. Pharmacol. 5:53-59 (Pubitemid 40124535)
289. Woolf NJ. 1991. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:475-524
290. Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA. 2003. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J. Neurosci. 23:3176-85
291. Zhang H, Sulzer D. 2004. Frequency-dependent modulation of dopamine release by nicotine. Nat. Neurosci. 7:581-82 (Pubitemid 38691893)
292. Zhang L, Doyon WM, Clark JJ, Phillips PE, Dani JA. 2009a. Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol. Pharmacol. 76:396-404
293. Zhang T, Zhang L, Liang Y, Siapas AG, Zhou FM, Dani JA. 2009b. Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. J. Neurosci. 29:4035-43
294. Zhou FM, Liang Y, Dani JA. 2001. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4:1224-29 (Pubitemid 33135628)
295. Zhou FM, Wilson C, Dani JA. 2003. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 9:23-36 (Pubitemid 36139576)
296. Zhou FM, Wilson CJ, Dani JA. 2002. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J. Neurobiol. 53:590-605 (Pubitemid 35375589)